GRM5 and Huntington disease: To investigate potential sex-specific differences in the contribution of pathological mGluR5 signaling to HD progression and pathology, we first assessed whether targeted mGluR5 antagonism would improve motor deficits in symptomatic heterozygous male and female zQ175 mice.